ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $241,000 | -5.1% | 23,002 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $254,000 | -72.4% | 23,002 | -79.1% | 0.00% | -75.0% |
| Q1 2017 | $921,000 | +51.2% | 110,019 | +25.5% | 0.00% | +33.3% |
| Q4 2016 | $609,000 | +372.1% | 87,688 | +245.0% | 0.00% | +200.0% |
| Q3 2016 | $129,000 | -15.1% | 25,417 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $152,000 | +97.4% | 25,417 | -3.1% | 0.00% | – |
| Q1 2015 | $77,000 | -33.6% | 26,236 | 0.0% | 0.00% | – |
| Q4 2014 | $116,000 | -14.1% | 26,236 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $135,000 | 0.0% | 26,236 | +1.7% | 0.00% | 0.0% |
| Q2 2014 | $135,000 | +13400.0% | 25,801 | +5060.2% | 0.00% | – |
| Q2 2013 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |